Theatre 11

Tuesday 26th March

Wednesday 27th March

speaker

11.00 - 11.30

Christopher Curtis

From Cancer to the Palace in 6 years

From Cancer to the Palace in 6 years. How one word can change your life ‘Cancer’ Friday, 13 th May 2011 @ 11am, diagnosed with Throat Cancer my world fell apart. My First thought was ‘I am going to die. I remember the consultant saying, ‘The Biopsy was positive, you have CANCER’ the next thing to happen, was “Information Overload”.

speaker

11.45 - 12.15

Dr Richter-Heine

Benefits of supporting medical garments in breast surgery

Any kind of breast surgery leads to anatomical and physiological changes of the breast tissue. The postop care should provide optimized wound healing and recovery process. Therefore special medical bra types, customized to patient`s need are recommended. This talk shows the anatomical and physiological aspects of different kinds of breast surgery, results intra-op, post-op and as long term follow up in patient wearing supporting medical bra.

speaker

12.30 - 13.00

Joanne Edwards

Role of IKK alpha in Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast carcinoma with limited therapeutic options. IKKα, the main catalytic kinase in the NF-κB non-canonical pathway, may be a novel therapeutic target for treatment of TNBC as elevated levels of phosphorylated IKKα in TNBC specimens is associated with reduced cancer specific survival and treatment of TNBC cell lines with IKKα inhibitors results in reduced cell viability.

speaker

13.15 - 13.45

Hamed Javan MD

Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer

Pancreatic Cancer is a disease with poor prognosis. In 2017, its 5-year net survival rate is only 8% with only 2% in metastatic setting and it is third common cause of cancer related death. Only less than 20% of cases are eligible for surgery at diagnosis, so we tried to evaluate the role preoperative FOLFIRINOX in potentially curable pancreatic cancer in retrospective study and clinical trial.

speaker

14.00 - 14.30

Arie Parnham

Penile sparing and minimally invasive techniques for penile cancer

A review of the current literature and surgical advances in the management of penile cancer

speaker

14.45 - 15.15

Professor Sun Myint

Rectal cancer- Do patients have a choice?

Each year 12,000 patients are diagnosed with rectal cancer in the UK. The standard of care is radical surgery. Not all patients are suitable for surgery due to advancing age and their comorbidities. The mortality and morbidity is high following surgery in elderly patients. There is increase in ageing population in the UK. Contact X-ray brachytherapy[CXB] (Papillon) will be discuss as an alternative non-surgical treatment option for patients not suitable for surgery.